Glenn R. Mattes - Net Worth and Insider Trading

Glenn R. Mattes Net Worth

The estimated net worth of Glenn R. Mattes is at least $2,890 dollars as of 2024-11-10. Glenn R. Mattes is the President and CEO of TFF Pharmaceuticals Inc and owns about 1,720 shares of TFF Pharmaceuticals Inc (TFFP) stock worth over $2,890. Details can be seen in Glenn R. Mattes's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Glenn R. Mattes has not made any transactions after 2022-05-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Glenn R. Mattes

To

Glenn R. Mattes Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Glenn R. Mattes owns 2 companies in total, including TFF Pharmaceuticals Inc (TFFP) , and Arno Therapeutics Inc (ARNI) .

Click here to see the complete history of Glenn R. Mattes’s form 4 insider trades.

Insider Ownership Summary of Glenn R. Mattes

Ticker Comapny Transaction Date Type of Owner
TFFP TFF Pharmaceuticals Inc 2022-05-16 director & President and CEO
ARNI Arno Therapeutics Inc 2014-01-24 director & President & CEO

Glenn R. Mattes Latest Holdings Summary

Glenn R. Mattes currently owns a total of 1 stock. Glenn R. Mattes owns 1,720 shares of TFF Pharmaceuticals Inc (TFFP) as of May 16, 2022, with a value of $2,890.

Latest Holdings of Glenn R. Mattes

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TFFP TFF Pharmaceuticals Inc 2022-05-16 1,720 1.68 2,890

Holding Weightings of Glenn R. Mattes


Glenn R. Mattes Form 4 Trading Tracker

According to the SEC Form 4 filings, Glenn R. Mattes has made a total of 7 transactions in TFF Pharmaceuticals Inc (TFFP) over the past 5 years, including 2 buys and 5 sells. The most-recent trade in TFF Pharmaceuticals Inc is the acquisition of 640 shares on May 16, 2022, which cost Glenn R. Mattes around $76,480.

Insider Trading History of Glenn R. Mattes

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Glenn R. Mattes Trading Performance

GuruFocus tracks the stock performance after each of Glenn R. Mattes's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Glenn R. Mattes is 4.06%. GuruFocus also compares Glenn R. Mattes's trading performance to market benchmark return within the same time period. The performance of stocks bought by Glenn R. Mattes within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Glenn R. Mattes's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Glenn R. Mattes

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 4.05 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 4.44 LIMIT LIMIT LIMIT LIMIT LIMIT

Glenn R. Mattes Ownership Network

Ownership Network List of Glenn R. Mattes

No Data

Ownership Network Relation of Glenn R. Mattes

Insider Network Chart

Glenn R. Mattes Owned Company Details

What does TFF Pharmaceuticals Inc do?

Who are the key executives at TFF Pharmaceuticals Inc?

Glenn R. Mattes is the director & President and CEO of TFF Pharmaceuticals Inc. Other key executives at TFF Pharmaceuticals Inc include 10 percent owner Carlson Capital L P , 10 percent owner Clint Duane Carlson , and 10 percent owner Double Black Diamond Offshore Ltd .

TFF Pharmaceuticals Inc (TFFP) Insider Trades Summary

Over the past 18 months, Glenn R. Mattes made no insider transaction in TFF Pharmaceuticals Inc (TFFP). Other recent insider transactions involving TFF Pharmaceuticals Inc (TFFP) include a net purchase of 600,000 shares made by Harlan F Weisman , a net sale of 216,000 shares made by Carlson Capital L P , and a net purchase of 120,000 shares made by Zamaneh Mikhak .

In summary, during the past 3 months, insiders sold 0 shares of TFF Pharmaceuticals Inc (TFFP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,640 shares of TFF Pharmaceuticals Inc (TFFP) were sold and 32,800 shares were bought by its insiders, resulting in a net purchase of 24,160 shares.

TFF Pharmaceuticals Inc (TFFP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

TFF Pharmaceuticals Inc Insider Transactions

No Available Data

Glenn R. Mattes Mailing Address

Above is the net worth, insider trading, and ownership report for Glenn R. Mattes. You might contact Glenn R. Mattes via mailing address: 200 Route 31 North, Suite 104, Flemington Nj 08822.